Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?

Transl Cancer Res. 2019 Oct;8(6):2223-2229. doi: 10.21037/tcr.2019.08.18.
No abstract available

Publication types

  • Editorial
  • Comment